Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study
Status:
Completed
Trial end date:
2018-02-22
Target enrollment:
Participant gender:
Summary
Prospective, single-arm, open-label, multicentre study with the principal aim to estimate
tacrolimus pharmacokinetic parameters in elderly de-novo kidney transplant recipients of ECD
(Extended Criteria Donor) kidney grafts treated with Envarsus® prolonged release tablets in
combination with everolimus tablets.